Chicago, IL · Founded 2019 · Privately Held (backing)
Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness. CiRC Biosciences is based in Chicago, IL and was founded in 2019. Its last reported valuation was $24 million in Dec 2020. It has raised $39.1 million across 2 recorded rounds; the latest was a $7 million debt round in Apr 2024.
Last reported valuation
$24.0M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
Debt
Apr 2024
Cap table — not yet on record
CiRC Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CiRC Biosciences with a free account
·Watch CiRC Biosciences: the Monday email on marks, rounds and moves
Where does CiRC Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across CiRC Biosciences's 2 recorded funding rounds.
